Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Proellex for endometriosis was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Endometriosis | Phase 2 | Status: TERMINATED | Results posted: 2019-02-12